Showing results (131-140 of 9,095) with videos related to
Sort By:
Pageof 910
Cancer Medicine|May 23, 2019
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapyJohanna Moreau, Marie-Amélie Ordan, Coralie Barbe, et al.Cancer Medicine|May 23, 2019
The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trialNadja Klafke, Cornelia Mahler, Cornelia von Hagens, et al.Cancer Medicine|May 25, 2019
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare studyRohit Bishnoi, Young-Rock Hong, Chintan Shah, et al.Cancer Medicine|May 26, 2019
Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single-center studyLijie Song, Xuejia Zhai, Shunli Yu, et al.Cancer Medicine|May 26, 2019
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.Cancer Medicine|May 28, 2019
The impact of pricing strategy on the costs of oral anti-cancer drugsJudy Truong, Kelvin K W Chan, Helen Mai, et al.Cancer Medicine|May 29, 2019
Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER databaseShijing Chen, Huaquan Chen, Ying Yi, et al.Cancer Medicine|October 8, 2021
Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodineCanhua Yun, Juan Xiao, Jingjia Cao, et al.Cancer Medicine|October 10, 2021
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysisEtsuro Bando, Xinge Ji, Michael W Kattan, et al.Cancer Medicine|October 14, 2021
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitorsNicholas Gulati, Arda Celen, Paul Johannet, et al.Pageof 910